Literature DB >> 26958159

Content and Usability Evaluation of Patient Oriented Drug-Drug Interaction Websites.

Terrence J Adam1, Joseph Vang2.   

Abstract

Drug-Drug Interactions (DDI) are an important source of preventable adverse drug events and a common reason for hospitalization among patients on multiple drug therapy regimens. DDI information systems are important patient safety tools with the capacity to identify and warn health professionals of clinically significant DDI risk. While substantial research has been completed on DDI information systems in professional settings such as community, hospital, and independent pharmacies; there has been limited research on DDI systems offered through online websites directly for use by ambulatory patients. The focus of this project is to test patient oriented website capacity to correctly identify drug interactions among well established and clinically significant medication combinations and convey clinical risk data to patients. The patient education capability was assessed by evaluating website Information Capacity, Patient Usability and Readability. The study results indicate that the majority of websites identified which met the inclusion and exclusion criteria operated similarly, but vary in risk severity assessment and are not optimally patient oriented to effectively deliver risk information. The limited quality of information and complex medical term content complicate DDI risk data conveyance and the sites may not provide optimal information delivery to allow medication consumers to understand and manage their medication regimens.

Entities:  

Mesh:

Year:  2015        PMID: 26958159      PMCID: PMC4765624     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  16 in total

Review 1.  The role of pharmacy computer systems in preventing medication errors.

Authors:  Elizabeth A Chrischilles; Thomas R Fulda; Patricia J Byrns; Susan C Winckler; Michael T Rupp; Michelle A Chui
Journal:  J Am Pharm Assoc (Wash)       Date:  2002 May-Jun

2.  Concordance of severity ratings provided in four drug interaction compendia.

Authors:  Jacob Abarca; Daniel C Malone; Edward P Armstrong; Amy J Grizzle; Philip D Hansten; Robin C Van Bergen; Richard B Lipton
Journal:  J Am Pharm Assoc (2003)       Date:  2004 Mar-Apr

3.  Ability of pharmacy clinical decision-support software to alert users about clinically important drug-drug interactions.

Authors:  Kim R Saverno; Lisa E Hines; Terri L Warholak; Amy J Grizzle; Lauren Babits; Courtney Clark; Ann M Taylor; Daniel C Malone
Journal:  J Am Med Inform Assoc       Date:  2010-12-03       Impact factor: 4.497

4.  Evaluation of the performance of drug-drug interaction screening software in community and hospital pharmacies.

Authors:  Jacob Abarca; Lisa R Colon; Victoria S Wang; Daniel C Malone; John E Murphy; Edward P Armstrong
Journal:  J Manag Care Pharm       Date:  2006-06

5.  A new readability yardstick.

Authors:  R FLESCH
Journal:  J Appl Psychol       Date:  1948-06

6.  Performance of community pharmacy drug interaction software.

Authors:  T K Hazlet; T A Lee; P D Hansten; J R Horn
Journal:  J Am Pharm Assoc (Wash)       Date:  2001 Mar-Apr

7.  Clinical and economic impact of adverse drug reactions in hospitalized patients.

Authors:  D C Suh; B S Woodall; S K Shin; E R Hermes-De Santis
Journal:  Ann Pharmacother       Date:  2000-12       Impact factor: 3.154

8.  Improving recognition of drug interactions: benefits and barriers to using automated drug alerts.

Authors:  Peter A Glassman; Barbara Simon; Pamela Belperio; Andrew Lanto
Journal:  Med Care       Date:  2002-12       Impact factor: 2.983

Review 9.  Epidemiology of drug-drug interactions as a cause of hospital admissions.

Authors:  C A Jankel; L K Fitterman
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

10.  Potential drug-drug interactions within Veterans Affairs medical centers.

Authors:  Maysaa Mahmood; Daniel C Malone; Grant H Skrepnek; Jacob Abarca; Edward P Armstrong; John E Murphy; Amy J Grizzle; Yu Ko; Raymond L Woosley
Journal:  Am J Health Syst Pharm       Date:  2007-07-15       Impact factor: 2.637

View more
  4 in total

Review 1.  How to meet patients' individual needs for drug information - a scoping review.

Authors:  Marcel Kp Kusch; Walter E Haefeli; Hanna M Seidling
Journal:  Patient Prefer Adherence       Date:  2018-11-06       Impact factor: 2.711

2.  Constructing a bilingual website with validated database for Herb and Western medicine interactions using Ginseng, Ginkgo and Dong Quai as examples.

Authors:  Chang-Shiann Wu; Yu-Huai Chen; Chi-Liang Chen; Sheng-Kan Chien; Nailis Syifa; Yu-Chun Hung; Kai-Jen Cheng; Shu-Chin Hu; Pei-Tzu Lo; Shun-Yung Lin; Tzu-Hua Wu
Journal:  BMC Complement Altern Med       Date:  2019-11-27       Impact factor: 3.659

3.  Patients' Use and Perceptions of a Drug-Drug Interaction Database: A Survey of Janusmed Interactions.

Authors:  Hanna Justad; Ylva Askfors; Tero Shemeikka; Marine L Andersson; Tora Hammar
Journal:  Pharmacy (Basel)       Date:  2021-01-19

4.  Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases.

Authors:  Michael Hecker; Niklas Frahm; Paula Bachmann; Jane Louisa Debus; Marie-Celine Haker; Pegah Mashhadiakbar; Silvan Elias Langhorst; Julia Baldt; Barbara Streckenbach; Felicita Heidler; Uwe Klaus Zettl
Journal:  Front Pharmacol       Date:  2022-08-05       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.